Dr. J Returns to GRG Banking for Annual AI Breast Cancer Screening Program
Employee health remains a top priority, and AI continues to play an increasingly important role in preventive healthcare.
On June 25, 2026, Dr. J, the AI-powered ultrasound breast cancer screening robot developed by Shangyiyun, returned to GRG Banking’s Data Industrial Park to provide another dedicated breast cancer screening program for female employees. Following the successful large-scale screening conducted last year, this year’s event marks the transition from a one-time health initiative to a routine, long-term breast health management program within the industrial park.
The screening program was jointly supported by the Guangdong Charity Federation, with clinical expertise provided by specialists from Guangzhou First People’s Hospital. Working together with multiple Dr. J AI screening systems, the team delivered efficient, professional breast cancer screening services for hundreds of female employees.
Using AI-powered ultrasound technology, the examinations were non-invasive, painless, and radiation-free, providing a comfortable screening experience while supporting early detection of potential breast abnormalities.
From One-Time Screening to Continuous Protection
“I participated last year, and I was pleasantly surprised to see Dr. J return this year. It feels reassuring to know that our health is being cared for continuously,” one employee shared after completing the screening.
Powered by Shangyiyun’s proprietary deep-learning vision foundation model, Dr. J can automatically detect suspicious breast lesions in real time and generate standardized BI-RADS classifications to assist clinicians in making accurate assessments.
With annual AI-assisted screening, employees are able to build long-term personal breast health records, compare examination results over time, and proactively monitor changes in their breast health. This integrated “screening + longitudinal follow-up” approach not only improves the effectiveness of early breast cancer detection but also transforms employee healthcare from periodic physical examinations into continuous lifecycle health management.
Expanding Access to AI-Powered Preventive Healthcare
Looking ahead, Shangyiyun will continue collaborating with charitable organizations, labor unions, healthcare institutions, and corporate partners to expand the adoption of AI-powered breast cancer screening programs across workplaces and industrial parks.
By making advanced AI medical technology more accessible through routine screening initiatives, Dr. J aims to provide sustainable health protection for more women in the workplace and contribute to earlier detection, better prevention, and improved health outcomes.
